How An Insurer Decides A Treatment Is Medically Necessary

Almost every health policy pays only for care that is medically necessary, and that phrase carries far more weight than most members realise. It is a contract definition, not a clinical judgement made at the bedside.

The definition lives in the policy, not in medicine

Policy wordings usually define necessary care as treatment that is appropriate for the condition, consistent with accepted practice, and not primarily for the convenience of the patient or the provider.

Each of those clauses does work. The convenience clause, for instance, is what excludes an inpatient stay for something that is routinely handled in a clinic without harm.

Because the definition is contractual, two insurers can reach different conclusions about the same patient without either behaving improperly. They are applying different wordings to the same facts.

Criteria sets do the actual deciding

Insurers rarely assess necessity from first principles. They license or build criteria sets that reduce a condition to a checklist of findings, failed alternatives and severity markers.

A reviewer compares the submitted record against that checklist. If the record does not state a required finding, the criterion is treated as unmet even where the finding was almost certainly present.

This is why documentation shapes outcomes so heavily. The decision is made on what the chart says, and a clinician who writes tersely can produce a denial for a well-justified treatment.

Review escalates through people, not systems

Initial review is often clerical or automated, matching codes and criteria. A reviewer at that level can approve but generally cannot deny on clinical grounds.

Denials on necessity are usually reserved for a clinician reviewer, because most jurisdictions require a medical professional to make an adverse clinical determination.

That structure creates a useful lever. A peer-to-peer conversation between the treating doctor and the reviewing clinician can resolve a case that no amount of paperwork would have moved.

Experimental and investigational is a separate gate

Treatment can be clearly necessary and still be excluded as experimental. These are distinct tests, and a letter sometimes conflates them in ways that mislead the reader.

Insurers typically judge investigational status by whether a treatment has regulatory approval for the specific indication and whether published evidence supports it for that use.

Off-label prescribing sits in the awkward middle. It is lawful and often standard practice, but a policy may still decline to fund it unless the wording recognises accepted compendia.

Why the reasoning matters more than the outcome

A denial letter must ordinarily identify the criterion that was not met and the basis for the determination. That statement is the map for any appeal.

If the stated reason is a missing clinical finding, the fix is evidentiary. If the reason is an exclusion in the wording, no additional records will help and the argument has to be about interpretation.

Definitions, review rights and appeal deadlines vary by jurisdiction and change over time, so the governing document remains the policy in force and the rules of the place where it was issued.